Affiliated Hospital of Jiangnan University
52
10
12
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 52 trials
100.0%
+13.5% vs industry average
13%
7 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (52)
The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer
Role: collaborator
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
Role: collaborator
Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer
Role: collaborator
Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients
Role: lead
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
Role: collaborator
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
Role: lead
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Role: lead
Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
Role: collaborator
Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with Colitis
Role: collaborator
Endoscopic Ultrasound-guided Fine-needle Aspiration of Solid Pancreatic Lesions With Rapid Staining of Cytological Smears Followed by Whole Slide Scanning and Artificial Intelligence Diagnosis: A Prospective, Multicenter Study.
Role: collaborator
Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer
Role: lead
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
Role: lead
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
Role: lead
Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)
Role: collaborator
Clinical Characteristics and Prognosis of Acute Stroke in Pregnancy and Puerperium
Role: collaborator
An Exploratory Study of Deep Cervical Lymphovenous Bypass (LVB) in Alzheimer's Disease
Role: lead
IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites
Role: lead
Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer
Role: lead
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study
Role: collaborator
Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer
Role: lead